Artwork

内容由Clinical Care Options, LLC and Clinical Care Options提供。所有播客内容(包括剧集、图形和播客描述)均由 Clinical Care Options, LLC and Clinical Care Options 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Providing Options for PrEP Reengagement: Strategies to Support PrEP Persistence and Reengagement

16:11
 
分享
 

Manage episode 389706577 series 2884624
内容由Clinical Care Options, LLC and Clinical Care Options提供。所有播客内容(包括剧集、图形和播客描述)均由 Clinical Care Options, LLC and Clinical Care Options 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In this episode, Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES, discusses data and recommendations for providing HIV prevention options as a strategy to support PrEP persistence and engagement, including:

  • Postexposure prophylaxis (PEP) recommendations and the data for PEP-in-Pocket
  • Offering PrEP to everyone who receives PEP
  • Currently recommended PrEP options and the safety and adverse event considerations with each option
  • Monitoring recommendations for the different PrEP options
  • The importance of proactively addressing PrEP safety concerns that could lead to PrEP discontinuation

Faculty

Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES
Assistant Professor
Pharmacotherapeutics and Clinical Research
University of South Florida Taneja College of Medicine
Tampa, Florida

Follow along with the slides:
bit.ly/48cULUN

Link to full program:
bit.ly/3ZlICsL

  continue reading

413集单集

Artwork
icon分享
 
Manage episode 389706577 series 2884624
内容由Clinical Care Options, LLC and Clinical Care Options提供。所有播客内容(包括剧集、图形和播客描述)均由 Clinical Care Options, LLC and Clinical Care Options 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In this episode, Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES, discusses data and recommendations for providing HIV prevention options as a strategy to support PrEP persistence and engagement, including:

  • Postexposure prophylaxis (PEP) recommendations and the data for PEP-in-Pocket
  • Offering PrEP to everyone who receives PEP
  • Currently recommended PrEP options and the safety and adverse event considerations with each option
  • Monitoring recommendations for the different PrEP options
  • The importance of proactively addressing PrEP safety concerns that could lead to PrEP discontinuation

Faculty

Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES
Assistant Professor
Pharmacotherapeutics and Clinical Research
University of South Florida Taneja College of Medicine
Tampa, Florida

Follow along with the slides:
bit.ly/48cULUN

Link to full program:
bit.ly/3ZlICsL

  continue reading

413集单集

Todos los episodios

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南